Hansoh Pharma Overview
- Year Founded
-
1995
- Status
-
Public
- Employees
-
9,643
- Stock Symbol
-
03692
- Investments
-
2
- Share Price
-
$4.32
- (As of Monday Closing)
Hansoh Pharma General Information
Description
Hansoh Pharmaceutical Group Co Ltd is an investment holding company. The company were principally engaged in the research and development, production and sale of a series of pharmaceutical products in the People's Republic of China. It focuses on disease therapeutic areas such as oncology, anti-infectives, CNS, metabolism and immunology. The majority of Group's revenue was generated from the sale of pharmaceutical products in Chinese mainland.
Contact Information
Website
www.hansoh.cnCorporate Office
- Number 9 Dongjin Road
- Huaguoshan Avenue
- Lianyungang, Jiangsu 222069
- China
Corporate Office
- Number 9 Dongjin Road
- Huaguoshan Avenue
- Lianyungang, Jiangsu 222069
- China
Hansoh Pharma Stock Performance
As of 16-Nov-2026, Hansoh Pharma’s stock price is $4.32. Its current market cap is $26.2B with 6.06B shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.32 | $4.39 | $3.58 - $5.68 | $26.2B | 6.06B | 10.9M | $0.16 |
Hansoh Pharma Financials Summary
As of 30-Jun-2026, Hansoh Pharma has a trailing 12-month revenue of $2.27B.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 18,441,106 | 23,771,669 | 9,973,322 | 9,333,127 |
| Revenue | 2,272,110 | 2,089,787 | 1,708,715 | 1,428,124 |
| EBITDA | 1,027,048 | 815,697 | 626,853 | 465,621 |
| Net Income | 954,428 | 772,523 | 609,275 | 463,259 |
| Total Assets | 6,859,493 | 5,702,739 | 4,336,632 | 4,660,875 |
| Total Debt | 623,103 | 15,020 | 16,150 | 607,135 |
Hansoh Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Hansoh Pharma Patents
Hansoh Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026233408-A1 | Polycyclic compounds, preparation methods and medicinal uses thereof | Pending | 09-May-2025 | ||
| WO-2026233425-A1 | Sirna, conjugate which contain sirna, pharmaceutical composition and uses thereof | Pending | 08-May-2025 | ||
| WO-2026228738-A1 | Tricyclic compound derivatives, preparation methods and medicinal uses thereof | Pending | 29-Apr-2025 | ||
| WO-2026228633-A1 | Antibody-drug conjugates and uses thereof | Pending | 28-Apr-2025 | ||
| WO-2026228677-A1 | Nitrogen-containing heterocyclic derivative inhibitor, preparation method therefor and use thereof | Pending | 28-Apr-2025 |
Hansoh Pharma Signals
Hansoh Pharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Hansoh Pharma Investments (2)
Hansoh Pharma’s most recent deal was a Early Stage VC with Blossom Bioscience for . The deal was made on 16-Jun-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Blossom Bioscience | 16-Jun-2021 | Early Stage VC | Drug Discovery | ||
| Blossom Bioscience | 10-May-2021 | Joint Venture | Drug Discovery |
Hansoh Pharma ESG
Risk Overview
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Hansoh Pharma FAQs
-
When was Hansoh Pharma founded?
Hansoh Pharma was founded in 1995.
-
Where is Hansoh Pharma headquartered?
Hansoh Pharma is headquartered in Lianyungang, China.
-
What is the size of Hansoh Pharma?
Hansoh Pharma has 9,643 total employees.
-
What industry is Hansoh Pharma in?
Hansoh Pharma’s primary industry is Drug Discovery.
-
Is Hansoh Pharma a private or public company?
Hansoh Pharma is a Public company.
-
What is Hansoh Pharma’s stock symbol?
The ticker symbol for Hansoh Pharma is 03692.
-
What is the current stock price of Hansoh Pharma?
As of 16-Nov-2026 the stock price of Hansoh Pharma is $4.32.
-
What is the current market cap of Hansoh Pharma?
The current market capitalization of Hansoh Pharma is $26.2B.
-
What is Hansoh Pharma’s current revenue?
The trailing twelve month revenue for Hansoh Pharma is $2.27B.
-
What is Hansoh Pharma’s annual earnings per share (EPS)?
Hansoh Pharma’s EPS for 12 months was $0.16.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process